Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,764 public trials 883 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

NCT04991753

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Arizona Arthritis & Rheumatology Associates PC Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Mesa, Arizona, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Tucson, Arizona, United States
  • Desert Medical Advances Palm Desert, California, United States
View all 28 locations
View Trial Details
Completed

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

NCT04835441

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Investigational Site (107) Anniston, Alabama, United States
  • Investigational Site (189) Phoenix, Arizona, United States
  • Investigational Site (155) Los Angeles, California, United States
  • Investigational Site (109) San Diego, California, United States
View all 46 locations
View Trial Details
Completed

Actis Total Hip System 2 Year Follow-up

NCT02783274

Conditions
Acute Traumatic Fracture of the Femoral Head or Neck, Arthritis, Arthritis, Rheumatoid, +26 more
Locations
  • Louisville, Kentucky, United States
  • Boston, Massachusetts, United States
  • Rochester, Minnesota, United States
  • Lebanon, New Hampshire, United States
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment

NCT01506141

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • Ann & Robert H Lurie Childrens Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Legacy Emanuel Hospital Portland, Oregon, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions